WallStSmart

The Coca-Cola Company (KO)vsNiagen Bioscience, Inc. (NAGE)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

The Coca-Cola Company generates 38734% more annual revenue ($50.13B vs $129.08M). KO leads profitability with a 28.6% profit margin vs 12.4%. NAGE trades at a lower P/E of 16.0x. KO earns a higher WallStSmart Score of 63/100 (C+).

KO

Buy

63

out of 100

Grade: C+

Growth: 6.0Profit: 9.5Value: 3.3Quality: 6.0
Piotroski: 6/9Altman Z: 2.49

NAGE

Hold

40

out of 100

Grade: D

Growth: 4.7Profit: 6.0Value: 6.0Quality: 8.5
Piotroski: 4/9Altman Z: 2.02
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

KOSignificantly Overvalued (-40.1%)

Margin of Safety

-40.1%

Fair Value

$63.02

Current Price

$88.29

$25.27 premium

UndervaluedFair: $63.02Overvalued

Intrinsic value data unavailable for NAGE.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

KO5 strengths · Avg: 9.4/10
Market CapQuality
$379.87B10/10

Mega-cap, among the largest globally

Return on EquityProfitability
39.6%10/10

Every $100 of equity generates 40 in profit

Operating MarginProfitability
34.9%10/10

Strong operational efficiency at 34.9%

Profit MarginProfitability
28.6%9/10

Keeps 29 of every $100 in revenue as profit

Free Cash FlowQuality
$5.10B8/10

Generating 5.1B in free cash flow

NAGE4 strengths · Avg: 8.8/10
Debt/EquityHealth
0.0310/10

Conservative balance sheet, low leverage

Return on EquityProfitability
22.6%9/10

Every $100 of equity generates 23 in profit

P/E RatioValuation
16.0x8/10

Attractively priced relative to earnings

Price/BookValuation
2.9x8/10

Reasonable price relative to book value

Areas to Watch

KO4 concerns · Avg: 3.3/10
P/E RatioValuation
26.5x4/10

Moderate valuation

Price/BookValuation
10.5x4/10

Trading at 10.5x book value

Debt/EquityHealth
1.203/10

Elevated debt levels

PEG RatioValuation
3.992/10

Expensive relative to growth rate

NAGE4 concerns · Avg: 2.5/10
Market CapQuality
$240.15M3/10

Smaller company, higher risk/reward

Operating MarginProfitability
2.4%3/10

Operating margin of 2.4%

Revenue GrowthGrowth
-4.3%2/10

Revenue declined 4.3%

EPS GrowthGrowth
-75.0%2/10

Earnings declined 75.0%

Comparative Analysis Report

WallStSmart Research

Bull Case : KO

The strongest argument for KO centers on Market Cap, Return on Equity, Operating Margin. Profitability is solid with margins at 28.6% and operating margin at 34.9%.

Bull Case : NAGE

The strongest argument for NAGE centers on Debt/Equity, Return on Equity, P/E Ratio.

Bear Case : KO

The primary concerns for KO are P/E Ratio, Price/Book, Debt/Equity.

Bear Case : NAGE

The primary concerns for NAGE are Market Cap, Operating Margin, Revenue Growth.

Key Dynamics to Monitor

KO profiles as a mature stock while NAGE is a declining play — different risk/reward profiles.

NAGE carries more volatility with a beta of 2.09 — expect wider price swings.

KO is growing revenue faster at 6.7% — sustainability is the question.

KO generates stronger free cash flow (5.1B), providing more financial flexibility.

Bottom Line

KO scores higher overall (63/100 vs 40/100), backed by strong 28.6% margins. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

The Coca-Cola Company

CONSUMER DEFENSIVE · BEVERAGES - NON-ALCOHOLIC · USA

The Coca-Cola Company is an American multinational beverage corporation incorporated under Delaware's General Corporation Law and headquartered in Atlanta, Georgia. The Coca-Cola Company has interests in the manufacturing, retailing, and marketing of nonalcoholic beverage concentrates and syrups.

Visit Website →

Niagen Bioscience, Inc.

CONSUMER DEFENSIVE · PACKAGED FOODS · USA

Niagen Bioscience, Inc. is a bioscience company engages in developing healthy aging products. The company is headquartered in Los Angeles, California.

Want to dig deeper into these stocks?